Tirzepatide
Dual GIP and GLP-1 receptor agonist studied for glycemic control and weight loss. Demonstrates superior metabolic improvements in rodent and primate models.
Category: Research Peptides
Brand: BioBoost Labs+™
Tirzepatide is a synthetic research peptide with dual agonist activity at both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This co-agonist profile makes it a powerful tool in studies involving metabolic regulation, glucose homeostasis, and energy balance. Tirzepatide is of high interest in experimental models exploring synergistic hormone signaling pathways.
- Preclinical models of glucose metabolism and insulin response
- Studies on co-agonist signaling (GIP/GLP-1)
- Laboratory research into appetite regulation and body composition
- Investigations focused on metabolic health and endocrine pathways
This product is intended strictly for laboratory research. It is not for human consumption, and not intended for diagnosis, treatment, or prevention of disease. By purchasing, the buyer affirms they are a qualified researcher age 21+ conducting lawful studies.
COAS:
Key Features:
- Peptide Type: Dual GIP and GLP-1 receptor agonist
- Peptide Sequence: [Proprietary – available upon request]
- Molecular Formula: C225H348N48O68
- CAS Number: 2023788-19-2
- Purity: >99% (HPLC)
- Form: Lyophilized powder
- Storage: Store at -20°C or as directed
- Shipping: Compliant with research shipping standards
This product has not been evaluated by the FDA and is not a drug. It is not intended to diagnose, treat, cure, or prevent any disease. For research use only.
